of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
NCT ID: NCT00925717
Last Updated: 2010-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4045 participants
OBSERVATIONAL
2009-05-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
NCT00891124
Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes
NCT01264263
High Sensitive CRP in Prediabetics and Diabetes
NCT03673904
High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes
NCT01099865
A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus
NCT05801432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2500 patients
Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
* Clinic visit in the past 6 months more than once
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MoonGyu Lee, Ph.D.
Role: STUDY_DIRECTOR
Samsung Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Cheonan-si, Chungchungnam-do, South Korea
Research Site
Chuncheon, Gangwon-do, South Korea
Research Site
Gangneung, Gangwon-do, South Korea
Research Site
Wŏnju, Gangwon-do, South Korea
Research Site
Ansan-si, Gyeonggi-do, South Korea
Research Site
Anyang-si, Gyeonggi-do, South Korea
Research Site
Bucheon-si, Gyeonggi-do, South Korea
Research Site
Goyang-si, Gyeonggi-do, South Korea
Research Site
Seongnam-si, Gyeonggi-do, South Korea
Research Site
Suwon, Gyeonggi-do, South Korea
Research Site
Uijeongbu-si, Gyeonggi-do, South Korea
Research Site
Gwangju-si, Jeollanam-do, South Korea
Research Site
Suncheon, Jeollanam-do, South Korea
Research Site
Jeonju, Jeonllabuk-do, South Korea
Research Site
Busan, , South Korea
Research Site
Cheonju-si, , South Korea
Research Site
Daegu, , South Korea
Research Site
Daejeon, , South Korea
Research Site
Incheon, , South Korea
Research Site
Jeonju, , South Korea
Research Site
Kwangju-si, , South Korea
Research Site
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CKR-DUM-2009/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.